Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

P. le Coutre; F. Giles; A Hochhaus; J. Apperley; G.J. Ossenkoppele; R. Blakesley; Y. Shou; N. Gallagher; M. Baccarani; J. Cortes; H. Kantarjian

doi:https://doi.org/10.1038/leu.2011.323

Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

P. le Coutre, F. Giles, A Hochhaus, J. Apperley, G.J. Ossenkoppele, R. Blakesley, Y. Shou, N. Gallagher, M. Baccarani, J. Cortes, H. Kantarjian

Hematology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

86 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1189-1194
Journal	Leukemia
Volume	26
Issue number	6
DOIs	https://doi.org/10.1038/leu.2011.323
Publication status	Published - 2012

Access to Document

https://doi.org/10.1038/leu.2011.323

Cite this

le Coutre, P., Giles, F., Hochhaus, A., Apperley, J., Ossenkoppele, G. J., Blakesley, R., Shou, Y., Gallagher, N., Baccarani, M., Cortes, J., & Kantarjian, H. (2012). Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results. Leukemia, 26(6), 1189-1194. https://doi.org/10.1038/leu.2011.323

@article{d2297b82ffa0443c90404fe46a5a255f,

title = "Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results",

author = "{le Coutre}, P. and F. Giles and A Hochhaus and J. Apperley and G.J. Ossenkoppele and R. Blakesley and Y. Shou and N. Gallagher and M. Baccarani and J. Cortes and H. Kantarjian",

year = "2012",

doi = "https://doi.org/10.1038/leu.2011.323",

language = "Undefined/Unknown",

volume = "26",

pages = "1189--1194",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "6",

}

le Coutre, P, Giles, F, Hochhaus, A, Apperley, J, Ossenkoppele, GJ, Blakesley, R, Shou, Y, Gallagher, N, Baccarani, M, Cortes, J & Kantarjian, H 2012, 'Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results', Leukemia, vol. 26, no. 6, pp. 1189-1194. https://doi.org/10.1038/leu.2011.323

TY - JOUR

T1 - Nilotinib in patients with Ph+ chronic myeloid leukemia in accelerated phase following imatinib resistance or intolerance: 24-month follow-up results

AU - le Coutre, P.

AU - Giles, F.

AU - Hochhaus, A

AU - Apperley, J.

AU - Ossenkoppele, G.J.

AU - Blakesley, R.

AU - Shou, Y.

AU - Gallagher, N.

AU - Baccarani, M.

AU - Cortes, J.

AU - Kantarjian, H.

PY - 2012

Y1 - 2012

U2 - https://doi.org/10.1038/leu.2011.323

DO - https://doi.org/10.1038/leu.2011.323

M3 - Article

C2 - 22076466

SN - 0887-6924

VL - 26

SP - 1189

EP - 1194

JO - Leukemia

JF - Leukemia

IS - 6

ER -